TP53 and skin basal cell carcinoma: To support a direct effect of 4SC‐202 on the growth of murine BCC cells, we treated ptch1/p53‐deficient cells also in vitro and found reduced cellular proliferation in response to 4SC‐202 as well as entinostat (Fig. 3j).